Effects Of 5-Fu And Anti-Egfr Antibody In Combination With Asa On The Spherical Culture System Of Hct116 And Ht29 Colorectal Cancer Cell Lines

The aim of this study was to examine the effects of 5-fluorouracil (5-FU), anti-epidermal growth factor receptor (EGFR) antibody and aspirin (ASA) on the characteristics of two CRC cell lines, HCT116 and HT29, maintained in a spherical culture system. We observed that the morphology of both the HCT116 and HT29 cell-derived spheres was significantly impaired and the size of the colonospheres was markedly reduced following treatment with the aforementioned three drugs. In contrast to adherent cultures, the spherical cultures were more resistant to the tested drugs, as was reflected by their capacity to re-create the colonospheres when sustained in serum-free medium. Flow cytometric analysis of the drug-treated HCT116 cell-derived spheres revealed changes in the fraction of cells expressing markers of cancer stem cells (CSCs), whereas the CSC phenotype of HT29 cell-derived colonospheres was affected to a lesser extent. All reagents enhanced the percentage of non-viable cells in the colonospheres despite the diminished fraction of active caspase-3-positive cells following treatment of the HT29 cell-derived spheres with anti-EGFR antibody. Increased autophagy, assessed by acridine orange staining, was noted following the incubation of the HT29-colonospheres with ASA and 5-FU in comparison to the control. Notably, the percentage of cyclooxygenase (COX)-2-positive cells was not affected by ASA, although its activity was markedly elevated in the colonospheres incubated with anti-EGFR antibody. On the whole, the findings of this study indicate that all the tested drugs were involved in different cellular processes, which suggests that they should be considered for the combined therapeutic treatment of CRC, particularly for targeting the population of CSC-like cells. Thus, cancer cell-derived spheres may be used as a preferable model for in vitro anticancer drug testing.